Land: Nieuw-Zeeland
Taal: Engels
Bron: Medsafe (Medicines Safety Authority)
Hyoscine butylbromide 20 mg/mL
Pharmacy Retailing (NZ) Ltd t/a Healthcare Logistics
Hyoscine butylbromide 20 mg/mL
20 mg/mL
Solution for injection
Active: Hyoscine butylbromide 20 mg/mL Excipient: Sodium chloride Water for injection
Ampoule, 1ml, 5 dose units
Prescription
Prescription
Boehringer Ingelheim Pharma GmbH & Co KG
Package - Contents - Shelf Life: Ampoule, 1ml - 5 dose units - 36 months from date of manufacture stored at or below 30°C
1969-12-31
1 BUSCOPAN TABLETS _Hyoscine butylbromide _ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Buscopan tablets. It does not contain all available information. It does not take the place of talking to your doctor or pharmacist. This leaflet was last updated on the date at the end of this leaflet. More recent information may be available. The latest Consumer Medicine Information is available from your pharmacist, doctor, or from www.medicines.org.au and www.medsafe.govt.nz/Consumers/c mi/CMIForm.asp (New Zealand) and may contain important information about the medicine and its use of which you should be aware. All medicines have risks and benefits. Your doctor has weighed the risks of you taking Buscopan against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS INFORMATION WITH THE MEDICINE. You may need to read it again. WHAT BUSCOPAN IS USED FOR Buscopan is known as an anticholinergic medicine. It relieves the pain of stomach and bowel cramps by helping your digestive system to relax. Buscopan blister packs of 20 tablets are available only at a pharmacy. Buscopan blister packs of 100 tablets are available only with a doctor's prescription. ALWAYS CONSULT YOUR DOCTOR OR PHARMACIST IF THE PAIN DOES NOT IMPROVE WITHIN 48 HOURS OR IF PAIN WORSENS AFTER TREATMENT. BEFORE YOU TAKE BUSCOPAN _WHEN YOU MUST NOT TAKE IT _ DO NOT TAKE BUSCOPAN IF YOU ARE ALLERGIC TO HYOSCINE BUTYLBROMIDE OR TO ANY OF THE OTHER INGREDIENTS LISTED AT THE END OF THIS LEAFLET. Some of the symptoms of an allergic reaction may include: • shortness of breath • wheezing or difficulty breathing • swelling of the face, lips, tongue or other parts of the body • rash, itching or hives on the skin. DO NOT TAKE THIS MEDICINE IF YOU HAVE FRUCTOSE INTOLERANCE. Buscopan contains sucrose as an ingredient. DO NOT TAKE BUSCOPAN IF YOU HAVE: • myasthenia gravis - a condition in which the muscles become wea Lees het volledige document
buscopan-ccdsv1-dsv7-d1-14nov22 Page 1 DATA SHEET 1 BUSCOPAN AND BUSCOPAN FORTE BUSCOPAN® 10 mg tablet and 20 mg/ml injection BUSCOPAN® FORTE 20 mg film coated tablet 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Hyoscine-N-butylbromide 10 mg tablet, 20 mg film coated tablet and 20 mg/ml injection Excipient with known effect: Lactose* *Only applicable for the product BUSCOPAN® FORTE 20 mg film coated tablet. For the full list of excipients, see Section 6.1. 3 PHARMACEUTICAL FORM Tablet 10 mg: white, unmarked, biconvex, sugar-coated. Tablet 20 mg: white, round, biconvex, film coated tablets embossed with the letter ‘B’ on one side and the number ‘20’ on the other side. Injection 20 mg/ml: clear, colourless solution in glass ampoules. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Muscle spasm of the gastrointestinal tract. 4.2 DOSE AND METHOD OF ADMINISTRATION ORAL: Adults and children over 6 years: 2 BUSCOPAN 10 mg tablets (20 mg) four times a day or 1 BUSCOPAN FORTE 20 mg tablet four times a day. buscopan-ccdsv1-dsv7-d1-14nov22 Page 2 The tablets should be swallowed whole with adequate fluid. PARENTERAL: Adults and adolescents over 12 years 1 or 2 ampoules (20 – 40 mg) may be administered by slow intravenous, intramuscular or subcutaneous injection several times a day. A maximum daily dose of 100mg should not be exceeded. Infants and young children: In severe cases, 0.3 - 0.6 mg/kg bodyweight, to be administered by slow intravenous, intramuscular or subcutaneous injection several times a day.The maximum daily dose of 1.2 mg/kg should not be exceeded. BUSCOPAN and BUSCOPAN FORTE should not be taken on a continuous daily basis or for extended periods without investigating the cause of abdominal pain. 4.3 CONTRAINDICATIONS BUSCOPAN and BUSCOPAN FORTE are contraindicated in myasthenia gravis, mechanical stenosis in the gastrointestinal tract, paralytical or obstructive ileus, megacolon and in patients who have demonstrated prior hypersensitivity to hyoscine butylbromide or any other component of the pr Lees het volledige document